Entrepreneurship in the Clinical World
Expert panel discussion jointly hosted by Queensland AI Hub, IntelliHQ, Society of Physician Entrepreneurs (SoPE)
Dr. Mark Luhovy, MD
Dr. Arlen Meyers, MD, MBA
Dr. Anthony Chang, MD, MBA, MPH, MS
Dr. Dimity Dornan, AO
Interview on the emergence of a new healthcare landscape, VR, AI and new technologies
With the explosion of powerful technologies, digital platforms, and endless opportunities, the healthcare landscape right now is one of the most dynamic sectors.
Amid so many medical devices, software systems, and procedures to streamline the healthcare operations, minimize costs, and optimize the quality of care there’s a lot to be excited about!
But the availability of ample resources leads to chaos and confusion. If you are one of the people brainstorming about which technologies to focus in 2020 to get successful in the healthcare industry, the answer lies right here.
We have insights from the leading doctors about what they think which technologies will have the highest impact on the future of healthcare delivery. We’ve put together the responses to let you envision how technology will shape the future of healthcare delivery.
- Health Tech Advisor
Interview on the future of healthcare delivery with a shift to healthcare-at-home services
The future of healthcare delivery will likely see a huge shift to healthcare-at-home and the landscape is expected to become even more patient-centric.
But what do the medical experts working on the frontline think of the future of healthcare delivery? To decode the mindset of medical professionals, we asked them a few questions:
Here we are with their inspiring responses and visions for what the future entails for healthcare delivery.
Global Health & Pharma are proud to announce the return of the sixth annual Biotechnology Awards. The Biotechnology Awards will once again cast a shining light on the pioneers within this evolving and crucial sector.
Boasting impressive market value growth and no signs of slowing, endeavours in biotechnology continue to make advancements in the laboratories and boardrooms across the globe. GHP is proud to recognise and acknowledge the innovative pioneers and dedicated leaders across the sector, including everything from chemists, clinicians and researchers, to manufacturers, consultants and those providing peripherals and specialist services.
Regardless of size and reach, all participants in the Biotechnology Awards are judged purely on merit; this approach enables us to ensure that only the most deserving are acknowledged.
The GHP team gather information independently from a variety of publicly accessible sources which are assessed alongside any material supplied by a nominating party or the nominee themselves. Final judgement is cast based on various criteria such as: business performance, longevity, business growth (either sustained or rapid) and any significant innovations or feedback.